Sign inGet started

Plutzky Jorge MD

Insider CIK 1576525 · AEGR Director · NVLN Director · VVUS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VVUS VIVUS INC A Award deriv2020-02-202020-02-2415,000— $015,000SEC↗
VVUS VIVUS INC A Award deriv2018-10-262018-10-2915,000— $015,000SEC↗
VVUS VIVUS INC A Award deriv2017-10-272017-10-31150,000— $0150,000SEC↗
VVUS VIVUS INC M Exercise deriv2017-10-272017-10-3112,500— $00SEC↗
VVUS VIVUS INC M Exercise2017-10-272017-10-3112,500— $084,921SEC↗
VVUS VIVUS INC D To issuer2017-10-272017-10-313,762$0.70 $2.6K81,159SEC↗
VVUS VIVUS INC M Exercise deriv2017-08-082017-08-1012,500— $012,500SEC↗
VVUS VIVUS INC M Exercise2017-08-082017-08-1012,500— $076,183SEC↗
VVUS VIVUS INC D To issuer2017-08-082017-08-103,762$1.01 $3.8K72,421SEC↗
VVUS VIVUS INC D To issuer2017-06-152017-06-193,762$1.17 $4.4K63,683SEC↗
VVUS VIVUS INC M Exercise deriv2017-05-082017-06-1912,500— $025,000SEC↗
VVUS VIVUS INC M Exercise2017-05-082017-06-1912,500— $067,445SEC↗
VVUS VIVUS INC M Exercise deriv2017-02-082017-02-1012,500— $037,500SEC↗
VVUS VIVUS INC M Exercise2017-02-082017-02-1012,500— $058,707SEC↗
VVUS VIVUS INC D To issuer2017-02-082017-02-103,762$1.08 $4.1K54,945SEC↗
VVUS VIVUS INC A Award deriv2017-01-132017-01-1850,000— $050,000SEC↗
NVLN NOVELION THERAPEUTICS INC. A Award deriv2016-12-222016-12-279,600— $09,600SEC↗
AEGR Aegerion Pharmaceuticals, D To issuer deriv2016-11-292016-11-3031,182— $00SEC↗
VVUS VIVUS INC M Exercise deriv2016-10-312016-11-013,125— $00SEC↗
VVUS VIVUS INC M Exercise2016-10-312016-11-013,125— $047,147SEC↗
VVUS VIVUS INC D To issuer2016-10-312016-11-01940$1.05 $98746,207SEC↗
VVUS VIVUS INC M Exercise deriv2016-09-302016-10-043,125— $03,125SEC↗
VVUS VIVUS INC D To issuer2016-09-302016-10-04940$1.14 $1.1K44,022SEC↗
VVUS VIVUS INC M Exercise2016-09-302016-10-043,125— $044,962SEC↗
VVUS VIVUS INC M Exercise deriv2016-08-312016-09-023,125— $06,250SEC↗
VVUS VIVUS INC D To issuer2016-08-312016-09-02949$1.06 $1.0K41,837SEC↗
VVUS VIVUS INC M Exercise2016-08-312016-09-023,125— $042,786SEC↗
VVUS VIVUS INC M Exercise deriv2016-07-312016-08-023,125— $09,375SEC↗
VVUS VIVUS INC D To issuer2016-07-312016-08-02940$1.07 $1.0K39,661SEC↗
VVUS VIVUS INC M Exercise2016-07-312016-08-023,125— $040,601SEC↗
VVUS VIVUS INC M Exercise deriv2016-06-302016-07-053,125— $012,500SEC↗
VVUS VIVUS INC M Exercise2016-06-302016-07-053,125— $038,416SEC↗
VVUS VIVUS INC D To issuer2016-06-302016-07-05940$1.12 $1.1K37,476SEC↗
VVUS VIVUS INC M Exercise deriv2016-05-302016-06-0121,875— $015,625SEC↗
VVUS VIVUS INC M Exercise2016-05-302016-06-0121,875— $041,875SEC↗
VVUS VIVUS INC D To issuer2016-05-302016-06-016,584$1.23 $8.1K35,291SEC↗
VVUS VIVUS INC A Award deriv2016-04-292016-05-0337,500— $037,500SEC↗
VVUS VIVUS INC A Award deriv2015-10-302015-11-0325,000— $025,000SEC↗
VVUS VIVUS INC A Award deriv2015-05-272015-05-2925,000— $025,000SEC↗
AEGR Aegerion Pharmaceuticals, A Award deriv2015-04-082015-04-1031,182— $031,182SEC↗
VVUS VIVUS INC A Award deriv2013-08-142013-08-1625,000— $025,000SEC↗
VVUS VIVUS INC A Award2013-05-102013-05-1320,000— $020,000SEC↗